AR and renal cell carcinoma: Correspondingly, the novel long non-coding RNA lncRNA-SARCC (lncRNA-suppressing androgen receptor in renal cell carcinoma) has been shown to inhibit the AR protein by binding to it and destabilizing it, thus increasing the miR-143-3p level in RCC.